Literature DB >> 3090198

Apparent neuroleptic malignant syndrome with clozapine and lithium.

H G Pope, J O Cole, P T Choras, C E Fulwiler.   

Abstract

Clozapine is an antipsychotic drug reported to be virtually free of extrapyramidal effects. On the basis of this, we hypothesized that it would be unlikely to cause the neuroleptic malignant syndrome (NMS), a rare but severe reaction observed with other antipsychotic drugs. However, when we administered clozapine (in conjunction with lithium) to a patient with a past history of NMS with fluphenazine, the syndrome reappeared after about 3 weeks of treatment. This represents, to our knowledge, the first report of apparent NMS with clozapine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090198     DOI: 10.1097/00005053-198608000-00010

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  17 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

2.  Rechallenging clozapine after neuroleptic malignant syndrome.

Authors:  Emaya Anbalagan; Muaid Ithman; John Lauriello
Journal:  Psychiatr Q       Date:  2014-09

Review 3.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Lithium dosage and leukocyte counts in psychiatric patients.

Authors:  L K Oyewumi; M McKnight; Z Z Cernovsky
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

5.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 6.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

Review 7.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 8.  Neuroleptic malignant syndrome.

Authors:  M S Jahan; A I Farooque; Z Wahid
Journal:  J Natl Med Assoc       Date:  1992-11       Impact factor: 1.798

9.  Neuroleptic malignant syndrome: a review for neurohospitalists.

Authors:  Brian D Berman
Journal:  Neurohospitalist       Date:  2011-01

Review 10.  Aetiology and treatment of neuroleptic malignant syndrome.

Authors:  C Harpe; A Stoudemire
Journal:  Med Toxicol       Date:  1987 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.